Hammad, G., El Tanawy, R., Fathy, A., Baraka, E., Salem, S. (2023). Assessment of Double Chin with Exercises and Mesotherapy. Benha Journal of Applied Sciences, 8(12), 31-37. doi: 10.21608/bjas.2024.253345.1291
Gamal Hammad; Refaat El Tanawy; Amal Fathy; Eman Baraka; Shymaa Salem. "Assessment of Double Chin with Exercises and Mesotherapy". Benha Journal of Applied Sciences, 8, 12, 2023, 31-37. doi: 10.21608/bjas.2024.253345.1291
Hammad, G., El Tanawy, R., Fathy, A., Baraka, E., Salem, S. (2023). 'Assessment of Double Chin with Exercises and Mesotherapy', Benha Journal of Applied Sciences, 8(12), pp. 31-37. doi: 10.21608/bjas.2024.253345.1291
Hammad, G., El Tanawy, R., Fathy, A., Baraka, E., Salem, S. Assessment of Double Chin with Exercises and Mesotherapy. Benha Journal of Applied Sciences, 2023; 8(12): 31-37. doi: 10.21608/bjas.2024.253345.1291
Assessment of Double Chin with Exercises and Mesotherapy
Rheumatology, Rehabilitation and Physical Medicine Dept., Faculty of Medicine, Benha University
Abstract
Background: Double A combination of workouts and mesotherapy is a common component of chin treatments. The purpose of this research was to evaluate the efficacy of workouts and mesotherapy in treating double chins. Methods: Thirty female patients, ranging in age from 22 to 55 years (with a mean age of 44.5 years ± 5.6 SD), were given a mixture that included Phosphatidyle choline, 20% caffeine, and 0.5% organic silicium. The treatment plan called for as many as six treatments, one week apart, with a point-by-point injection of the mixture (0.3 ml per location). After their injections, patients were given aftercare instructions and exercises to undertake every day to help reduce the appearance of a double chin. Blinded picture review by physicians, patient self-assessment surveys, and adverse effect monitoring were all part of the examination. Results: After the therapy, 90% of the 30 female participants (with an average age of 44.5 ± 5.6 years) who had moderate to substantial submental fat deposits reported feeling better. In particular, 16.7% saw a moderate improvement, and 26.7% saw a considerable improvement or a very significant improvement. In determining whether a patient had improved, raters reached a strong consensus (k=0.84). Edema (23.3% of patients), pain (23.3% of patients), erythema (16.7% of patients), and two cases of subcutaneous nodules were among the adverse events. Consistent with patient reports, clinician evaluations confirmed the treatment's success. Although there were few adverse reactions, they were generally mild and easily controlled.
View on SCiNiTO
Top